Table of Contents
Ear care once again registered a decline in 2012, falling by 3% in current value terms. This development fully corresponded with the performance during the review period, which saw a negative CAGR of 3% in current value terms. The poor performance of ear care in 2012 and during the review period can be attributed to the low demand for such OTC products. Swiss consumers with ear ache or other ear problems would rather seek a doctor’s advice than try self-medication. When it comes to ear...
Euromonitor International's Ear Care in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Ear Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...
The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...
This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate - Revenues by players - Top 5 Companies - Market ...